C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/19 (2006.01) A61K 38/18 (2006.01) C07K 14/475 (2006.01) C12N 5/10 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2289720
A variant hepatocyte growth factor (HGF) which is substantially incapable of binding a heparan sulphate proteoglycan but which is capable of binding to the HGF receptor for use in medicine.
On décrit un facteur mutant de croissance de la cellule hépatique, qui est généralement incapable de se fixer à l'héparane-sulphate protéoglycane, mais se lie au récepteur du facteur de croissance de la cellule hépatique pour un usage médical.
Birchmeier Walter
Gherardi Ermanno
Hartmann Guido
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Imperial Cancer Research Technology Limited
Medical Research Council
LandOfFree
Hgf polypeptides and their use in therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hgf polypeptides and their use in therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hgf polypeptides and their use in therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1552328